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Effects of chronic caffeine pre-exposure on conditioned and
unconditioned psychomotor activity induced by nicotine and
amphetamine in rats
M.I. Palmatiera, E.Y.K. ~

u andn R.A.~ Bevinsa
~

Three experiments examined the effects of chronic preexposure to caffeine on the subsequent conditioned and
unconditioned locomotor activating effects of nicotine or
amphetamine in rats. Rats were given daily intraperitoneal
injections of caffeine anhydrous (0,10 or 30 mg/kg base)
for 30 days. Conditioning (environment-drug pairings)
began after the last day of caffeine pre-exposure. Preexposure to 30 mg/kg of caffeine enhanced the acute and
chronic locomotor effects of amphetamine (0.5 mg/kg).
A similar enhancement of activity was not seen with the
high (0.421mg/kg base) or low dose (0.175 mg/kg) of
nicotine. In a drug-free test, the distinct environment paired
with amphetamine and the high dose of nicotine evoked
increases in activity relative to controls. Caffeine
pre-exposure did not affect expression of this conditioned
hyperactivity. These effects of caffeine pre-exposure on
amphetamine-induced activity could not be attributed to

Introduction
Acute nicotine cliallcngc is cliaractcrized by d c ~ t ~ c s s c d
tno tor activity rclativc to saline-injected con trols (0.2100.421rngjlrg, Stolcnnan c.t ul., 1973,1995;Bevins r t crL,
2001).lblerancc to these locomotor dcpressant cffccts is
observed by tllc second injection (Stolcrman ~ t c r l .1973;
,
Clark and IZi~miu; 1983). This locolnotor supprcssion
tends to be replaced with Iiypcractivity after repcatcd
daily exposure to nicotinc (0.210-0.421mg/lcg; Clark and
ICumar, 1983;Kita (.r rd., 1992;ICsir, 1994;Bcvins (V frL,
2001). Rats also show heiglitened activity rclneive to
controls with repeatcd administration of amphctariiine
(e.g. Schoffelmeer r t crl., 2002). In contrast to nicotinc,
amlphetamine doses typically used to study hchaviornl
activation do not induce an initial suppression of
locomotor activity (Browman r t rrl., 1998; Fraioli lJt ul.,
1999;0.125-1.0mg/kg in our laboratory, see later). In fact,
the stimulant effccts of amphetamine can be seen on the
first administration (e.g. Urowlnan rt ~ d1998).
,
Conditioning to environmental cues reliably associated
with tlie drug can contribute to the loco~notoractivating
effects of nicotinc and atnplietamine (Vezina ~t(N!, 1989;
Reid c't dl., 1996,1998;Ffi~ioliel nl., 1999;Bevins et [ I / . ,
2001). From this perspective, tlic effects of tlie drug on
the nervous system are the unco~iditioncdstimuli (USs),
while the resulting behavioral changes (e.g. locomotor
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hypcmctivity) arc the unconditioned rcsponscs (UIis).
When these ilnco~lrtitioneddrug effects rcliably occur in
the presence of environnicntal cucs (i.e. conditioned
stimuli or C:Ss), thc drug effects and cues can bccorne
nssociatcd vi:~ 1'avlovi:ui conditioning processes. For
cxalnplc, in our laboratory, nicotine-conditioned liyperactivity is cvirlenccd as more activity relativc to controls
in the absence of nicotine but in rllc presence of
environment:~l cucs (contest C:S) that have been
rcpciltcrlly p:lircd with nicotine (Bcvins et rn!, 2001;
I-'i~lmnticrand 13cvins, 2002;see Iicid t/ rd, 1998 for an
altcrnativc testing protocol).
C:hronic exposure to one drug might promote increased
behavioral sensitivity to another drug (c.g. Vexilia fl d,
1989;Ligi~orifl crl., 1997;Fenu r t rd, 2000;Bcycr c~ rd,
2001;I,amarque r t d , 2001;Pontieri ~ t d2001;
,
Cauli and
Morclli, 2002).In one such study, repeated daily exposure
to the dopiunine (DA) DZ receptor subtype agonist
brolliocriptirlc induced hyperactivity when rats were later
challenged with the non-specific adenosine antago~list
caffcinc or the adenosine A2A receptor subtype antagonist SCH 58261, regardless of test environment ( k n u
~tell,, 2000).Of particular interest in the present report
is the potential for 'cross-sensitization' between caffeine
and other drugs of abusc. Caffeine is prevalent in
a wide variety of foods, beverages, and over-the-counter
DOI: 10.1097101.fbp.0000069578.37661.2a
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medications. hedliolm et (11. (1999) estimate tliat cliilclren
aged 7-10 years ingest approximately 0.5-1.8mgllrg
caffeine/day, primarily from soft drinks and chocolate
products. 7% our knowledge, longitudinal assessment of
caffeine as a rislc factor for susceptibility to later drug use
lias riot been investigated in humans. liowever, some
studies have identified a relationship between caffeine
consumption and use of alcol~olor other abused drugs
(e.g. Istvan and Matarazzo, 1984; Brown and Renowitz,
1989; I<osslowslti et nl., 1993). Further, caffeine intalre is a
potential risk factor for relapse to tobacco use (e.g.
Cummings ut r7L, 1985; I<rall rt r d , 2002).
Recent studics using anirnal models have confirmed
these purported observations of cross-sensitization. Caffeine prc-exposurc can enhance tlie reinforcing (Shoaib PL
ol., 1999) and discriminative (Gasior et n/., 2000, 2002)
effects of nicotine, as well as the acute psychomotor
effects of nicotine, cocaine and amphetamine (Gasior ut
nl., 2000). T h e purpose of the present research was to
test the effects of chronic caffeine pre-exposure on the
subsequent acute and chronic unconditioned locomotor
activity induced by nicotine and a~nphetaminein rats.
Although caffeine pre-exposure might enhance thc acute
ambulatory effects of aniphetaniine and nicotine (e.g.
Gasior rt nlI, 2000), its chronic effects arc unclear, Also,
climnic drug exposure might be deleterious to associations formed between drugs and other cues (e.g. Cappcl
and Poulos, 1979; Iwan~otoand Williamson, 1984; Kunin et
nl., 1999, 2000; Palmatier and Bevins, 2001; but see
Shoaib rt n/., 1994; Bevins artd Palmatier, 2003). Thus,
drug (US) pre-exposure in a Pavlovian drug-conditioning
situation migllt facilitate or retard acquisition of conditioned associations, Accordingly, we also assessed how
chronic prc-exposure to caffeine affects the acquired
conditioned association between the context CS and the
psychomotor effects of nicotine or amphetamine (i.e.
context-dependent hyperactivity).

Method
Subjects

One hundrcd and fifteen naive male Spraguc-Dawley rats
from H a r l a ~Industries
l
(Indianapolis, Indiana, USA) were
housed individually in hanging wire-mesh cages. The rats
weighed 150-224g on arrival. Food and water were
continuously available in the home cage. Tlie colony
was maincained on a 12:12 light/darlr cycle; all procedures
were conducted in the light portion of t h e cycle. Each rat
was handled for approximately 2 min daily for 3 days prior
co the start of the experiment.
Apparatus

All pre-exposure injectiol~stoolc place in t h e home cage.
Conditioning was conducted in eight cylindrical I'VC
activity chambers measuring 30.5cm in diameter. Each
chamber was fitted with two infrared emicteddetector

units located 4 cm above the wire-mesh floor tlii~tdivided
the chamber into four equal sections. Infrared beanibrcalrs were recorded auto~natically by a personal
computer and served as the measure of activity.
Experiment 1A

This experiment sougl~t to examine tlic effects of
clironic caffeine pre-exposure on the unconditioned
and conditioned psychomotor effects of 0.421 mglkg
nicotine. In our laboratory, this dose of nicotine produces
robust conditioned hyperactivity on a drug-free test for
conditioning (Bevins e/ d ,2001; I'almatier and Bevins,
2002).
Procedure

Ccrffeiue $/Y-PX$(ISN~O. At the start of each experiment,
rats were randomly assigned (la = 20 per dose) to one of
three doses of caffeine (0, 10 or 30 mg/lrg). Each rat was
injected i.p. with its assigned dosc of caffeinc once daily
for 30 days. Injections occurred in the aftcrnoon
(16.30 r 111).
Co/~tex/-//ico/imP X I I ~ S L I ~(rondjtjo?/ing),
~
Rats from each
caffeine dose wcre randomly assigned to one of two
conditions (I'aircd or Unpaired; n = 10 per condition).
Nicotine conditioning began approximately 17 11 after the
last caffeine pre-exposure injection (day 31). Paired rats
were injecteci with 0.421 ~ n d k gnicotine s.c. imnicdiately
before placenient in the activity chambers. Unpaired rats
were injected s.c. with saline immediately before
placement. Conclitioni~ig continued once daily for 10
days. Locomotor activity (infrared beam-brealts) was
recorded for the entire 30-min conditioning trial. To
equate drug exposure, approximately 6 h after each
conditioning trial rats assigned to the Unpaired conditions were given s.c. injections of nicotine in tlie homc
cage; Paired rats were injected with saline. This temporal
separation produces no evidence of conditioned excitation or inhibition i l l the Unpaired condition. In fact, this
protocol results in an activity profile in the Unpaired
condition tliat is similar to that of rats never exposed to
nicotine (see Experiment 2 of Bevins ef nl., 2001).
Drzrg-fiee testfor conditio~zilzg. Twenty-four hours after the
last conditioning trial, rats wcre given a drug-free test.
Prior to placement in the activity chambers for the 30min test, all rats were injected s.c. with saline.
Experiment 1B

Experiment 1B assessed the effects of caffeine
pre-exposure on the subsequent unconditioned and
conditioned effects of a lower dose of nicotine
(0.175 mgllrg) that has wealr locomotor suppressing and
activating effects and does not support conditioning
(Bevins et nl., 2001). Using a lower nicotine dose might
reveal unconditioned and conditioned effects of caffeine
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pre-exposure l-rotcntially m;~sl~edby a higher tlicotine
close (i.c. ceiling effect).
Procedure

All experi~ncntalprocedures wcre identical to Experiment
lA, except as follows. Bused on findings from Experiment
1A (see lutcr), only tlie 0 and 3Omg/kg caff'cine prccxposurc doses were included in Experi111cnt 113, Also,
tlie nicotine dosc was reduced to 0.175 mg/I<g. For each
caffeine pre-exposure dose (0 or 30 mgjkg), eight rats
received nicotinc immediutcly bcforc placement in the
activity charnbcrs (Paired) and scvcn rats received
nicotine in tlie home cagc (Unpaired).
Experiment 2

Experimcnt 2 assessed the gcnclality of the results of
Experiment lA by ex311lining tile cf'fccts of chronic
caffeine exposure on tlic Inter psychosnotor effccts of
Given the diveranother stitnuliunt (i.e. amplietami~~e).
sity of locomotor conditionil~gprotocols with amphora~ n i ~ i(c.g.
c
Stew~lrt (lt (//, 1994; Ahmed ot ((/, 1996;
Bespelov and %vart:lu, 1996; Arvanitogiannis ~tcrL, 2000;
S ~ ~ t t o(nY ( I / , 2000), we conducted 21 pilot study to
examine ampl~et~uninc
(0.125, 0.25, 0.5 and 1.0 ~ng/lrg),
using the conditioning protocol dcscribcd for nicotine.
Meall activity counts for the dn~g-freetest for conditioning (11th session) are prcsetl~edin "1~1ble1. B:lsed on
these results, wc selected tlie 0.5 rng/lcg anlphctaminc
dose for Experiment 2 because it supported robust
conditioned hyperactivity after 10 trials (cf. thc
0.421 tng/lig nicotine dosc, Experirncnt 1A).
Procedure
I
- o

r . Prc-cxpos ure was similar co that
used in Expcrirnent 113. During this phase, o11e animal
was rernovccl due LO experimenter error. Thus, n~lalyses
included 20 rats in the 0 mglkg condition and 19 rats in
the 30 n~g/lcgconditio~i.

Table 1 Experimental conditions and mean ( f1 SEM) activity
counts on the drug-free test for activity (I1th session) of the pilot
experiment
Amphetamine dose

- -

0.125 malka
0.25mglkg
0.5 ~nglkg
1.0mglkg

Group
Paired (n=8)
Unpaired (n= 8)
Paired (n= 8)
Unpaired (n=8)
Paired (n=8)
Unpaired (n= 8)
Paired (11 = 8)
Unpaired (n=7)

Mean (-+ 1 SEMI activity
counts

447.60 (43.42)
328.90 (21.72)
527.40 (53.36)
275.90 (27.20)
591.40 (44.33)
31 3.30 (23.62)
498.80 (31.40)
31 8.90 (39.91)

Using a two-way ANOVA, the main effect of amphetamine dose
[F(3,65)=1.13,
p=0.34] and the Group Dose interaction [~(3,55)=
1.91,
P=0.141 were not significant. However, there was a significant main effecl of
Group [F(1,55)
=62.17, P<0.001I, indicating that Paired rats displayed
conditioned hyperactivity relative to Unpaired controls regardless of condition.
ing dose.

C o / / t ( ~ . ~ t - m l l p h ~cJx/~c~.sr~r(J
~ t c ~ ~ ~(tont/itiowit/g).
~i~~~~
LJnless mentioncd, the procectural details for context-amphetamine
cxposurc were identical to those in Experiments 1A and
113. I'aired groups (11 = 10 pcr pre-exposure condition)
received 0.5 mdlrg amphetamine i.p, immediately before
30-min exposure to the activity chambers; i.p. saline was
udministcred in tlie home cage approximately 0 h later.
LInpaircd (0 mg/l<g caffeine, n = 10; 30 mg/kg caffeine,
= 9) groups rcccived similnr treatnnent, except that
saline \yas administered before plizcement in the ilctivity
clinmbcrs and amphetamine was given in tlic home cage.
I)~.~{e~fii"('
t p . .for
~
I.~I/(/~I~IINLI,.
rl'lie 30-min drug-free tcs t
W:IS si~nili~r
to that of Experiments IA ;111d lB, cxcept that
saline wus i11.jcctcd i.p,
Drugs

Amphcta~nine hydrochloride and caffeine anhydrous
(Sigma, St. I,ouis, Missouri, USA) were dissolved in
salinc (0.9% NilCI) nllrl injected i.p. at 11 volumc of
Zml/kg for caffeine and Iml/lcg for amphetamine.
(-)-Nicotinc hydrogcn tartrate salt (Sigma) was dissolvcci in saline and brought to a pH of 7.0 r 0.2 with
a dilute NaOI-I solution. Nicoiinc was i ~ ~ j e c t c sac.
d
LIL a VDILII~IC of 1 ~nI/kg.I~OSC.S
of caffcille and ampl~ctatliinc nre expressed as tlie salt form; nicotine doscs are
cxprcssed as the hasc fonn.
Data analyses

Annlyses of vilriance (ANOVAs) were usecl for ovemll
comparisons. For cx,lmplc, omnibus ANOVAs including
one within-subjects factor, Trial, and two hcttvcensul?jects factors, Group (I'aired or Ilnpnircd) and Ilose
(cog.0, 10 or 30 &kg caffeine), wcre conducted as tests
for caffci~lcprc-exposure cfkcts on nicotitic- or atllphetumine-induced activity. R~rthcr, to :~ssess the lionspccific effects of caffeine exposure on activity, data fro111
IJnpairccl groups were analyzed sep:uatcly sing Chffcine
Ilosc as the between-sul~jects factor and 'Ilia1 as die
rcpcatcci measurc. This inancuvcr provided n more
sensitive test for possible non-specific effects of caffeine
exposure on activity. Drug-free tests were analyzed with
two-way ANOVAs in which Group and Dose were the
between-sub.ject factors. A two-tailed rejection criterion
(I-' I
0.05) w:ls used for all other analyses.

Results
Experiment 1A
Non-specific effects of caffeine pre-exposure

Caffei~lecall have ailorcctic effects. For example, Gans
(1984) found that, relative to saline controls, body weight
and food consumption were attenuated for rats chronically exposed to caffeine (see also ~~1Sllatier
and Bevins,
2()01). 'fi test this possibility, body weight on the last d21y
of caffeine pre-exposure (day 30) was compared for rats
pre-exposeci to each dose of caffeine (0, 10 or 30 mg/kg).
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There were no significant differences in body weight
between caffeine doses [P(2,57) = 1.75, NS].

Fig. 1

(A)

Figure 1A shows locolnotor activity across canditionillg
trials for Unpaired groups pre-exposed to caffeine or
saline. There was a significant main effect of Trial
[F(9,243) = 53.59, P < 0.0011, denoting that activity
decreased ovcr trials. T h e main effccts of Dose
and the Dose x Trial interaction werc not significant
[ F s < 11, indicating that, in our situation, caffeine
pre-exposure did not affect later motor activity in a
drug-free state.

Unpaired groups

5

U 0 mglkg caffeine
-A- 1 0 mglkg caffeine

3

U 3 0 mglkg caffeine

Nicotine-induced activity (0.421 mg/kg)

Omnibus ANOVA examined nicotinc-induced activity
for the Unpaired and Paired groups across conditioning
trials (Figs 1A, B). There wcre significant main effccts of
Trial [F(9,486) = 10.08, P < 0.0011, and of Group
[F( 1,54) = 25.48, P < 0.0011. T h e Group x Xial interaction was also significant [1;'(9,486) = 143.48, P < 0.011,
indicating that, as conditioning progressed, activity for
Paired rats increased relativc to that for Unpaired
controls. T h e niai~lcffect of Dose [F(2,54) = 2.20, NS]
ant1 the Group x Dose interilction [F(2,54) = 1.91, NS],
the Dose x Trial and the Group x Dose x Trial interactions [Fs < 11 wete not significant,

1

Experiment 1B
Non-specific effects of caffeine exposure

T h e body weight of rats on the last day of pre-exposure
did not differ significantly across caffeine doses (0 versus
30 mglkg) [F(1,28) = 1.57, NS]. Figure ZA shows mean
activity counts for the two Unpaired groups. Analyses
revealed
a significant ~nain effect of Trial
[F(9,117) = 7.78, P < 0.011, indicating that activity in
the Unpaired groups decreased over tlie 10 conditio~ling
trials. T h e ma,;, effect of Caffeine Dose and the Dose x
Trial interaction were not significant [Fs < 11, confirming
that chronic pre-exposure to caffeine does not affect
motor activity in a non-specific manner.

3

4

5

6

7

0

9

1

0

Trial

(8)

Paired groups

P
.-

r

Y

O

+0 mg/kg caffeine
-4-1 0 mglkg caffeine
-0- 3 0 mglkg caffeine

Drug-free test

Data from the drug-free test for conditioning are
presented in Fig. 1C. A two-way ANOVA revealed a
significant effect of Group [F(5,54) = 65.79, P < 0.0001],
indicating nicotine-conditiot~ed hyperactivity in the
Paired rats. T h e main effect of Dose and the Group x
Dose interaction were not significant [Fs(Z,54) 1 2.08,
NS] .

2

I

I

1

2

I

3

I

4

I

5

6

I

7

I

8

I

9

1~

1

0

Trial

(C)

Drug-free test

.r"

.-.,+
0

-5 9
2

I
I
Paired
350

r L )

ti
Fi

3

100
0

10
30
0
10
30
Caffeine pre-exposure dose (rnglkg)

Locomotor activity for rats treated with 0.421 mglkg nicotine
(Experiment 1A). (A) and (B) contrast caffeine pre-exposure conditions
for Unpaired and Paired groups across conditioning trials, respectively.
(C) Activity on the drug-free test for conditioning.

Nicotine-induced activity (0.175 mg/kg)

Omnibus ANOVA exatnilled activity for the Unpaired and
Paired groups across conditioning trials (Figs 2A and 2B,
respectively). There was a significant Group x 3 i a l
interaction [F(9,234) = 19.84, P < 0.0011, illdicati~lgthat
over the 10 conditio~~ing
trials, activity in Paired groups

increased and activity in Unpaired groups decreased. T h e
main effects of Group, Trial, and Dose were not
significant [Fs 2.84, NS]. T h e intcractions in which
Dose (0 or 30mg/kg) was a factor were not significant
either [Fs 5 1.26, NS].
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hyperactivity in our situatioll and that caffeine preexposure did not alter this outcome.

Fig. 2

(A)

Unpaired groups
600-

-+-0 mg/kg caffeine
.-A
>

+3 0 mglkg caffeine

+d

.+d

-5
m

s
,o

195

350-
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i.J

I

I

I

(B)

2

l

l

3

4

l

5

l

6
Trial

I

7

I

8

I

9

I

1

0

Paired groups

6001 +0 rnglkg caffeine

I

~.5
.,.,

+30

mgkg caffeine
T

Experiment 2
Non-specific effects of caffeine exposure

As in thc previous experiments, caffeine prc-exposure did
not altcr bocly weight [F(1,37)= 2.06, NS]. On the first
conditioning trial (day 31) 2111 equipment failure resulted
in tlie loss of data for 13 rats. Therefore, these data were
analyzed scparately from the remaining trials using a
Student's t-test (Ag. 3A). For Unpaired rats, there was no
difference in activity between caffeine pre-exposure
doscs on the first conditioning trial It < 11. Repeatedmeasures ANOVA examined possible non-specific effects
of caffeine in Unpaired rats on subsequent trials ( i s .
2-10). For the Unpaired groups, there was a significant
riiuin effect of rTrial [F(8,136) = 3.92, P < 0.051. T h e
main effect of Dose and thc Dose x Trial intcractio~~
were
not significant [Ps < 11, indicating that caffeine preexposure did not have a non-specific effect on activity.
Amphe tamine-induced activity (0.5 mg/kg)

'

0

I

(C)

2

3

4

5

°
6 7 8
Trial

9

1

9
0

Drug-free test

1111 Paired
0Unpaired

Caffeine pre-exposure dose (mglkg)
Locomotor activity for rats treated with 0.175 mg/kg nicotine
(Experiment 1B). (A) and (B) contrast 0 versus 3 0 mglkg caffeine preexposure for Unpaired and Paired groups, respectively. (C)Activity data
from the drug-free test for conditioning.

Drug-free test

Figure 2C shows activity from the drug-free test for
conditioning. T h e two-way ANOVA revealecl that the
main effect of Group, Dose, and the Dose x Group
interaction were not significant [A5 2.15, NS]. No main
effect of Group or Dose x Group interaction indicates
that 0.175 mg/kg nicotine did not support conditioned

Trid 1 data for caffeine prc-cxposcd (Paired tz = 7,
Unpaircd JI = 6) ancl non-prc-exposed (Paired n = 5,
Unpaired 11 = 8) rats were analyzcd separately with a
two-way ANOVA. Given the decrease in statistical power
due to loss of acute amplietaminc data, combined wit11
thc previous findings that cnffcinc potentiates activity
induced by aniphetamine in an acute challel~gc(Gasior
c>t ( r l , 2000), statistical significance for this analysis
cvas set at P I
0.10 (one-tailed). Tliere was a significant
mait1 effect of Group [F(1,22) = 12.06, P < 0.011, and
a significant Dose x Group interaction [F(1,22) = 4.07,
l J =0.0561. T h e main effect of Dose was not significant
[1;(1,22) = 2.62, NS]. Subsequent co~npilrisonsprompted
by the Dose x Group interaction examined amphetalninetreated rats ( i s . Paired groups) relative to comparable
saline-treated (Unpaired) controls. T h e comparisons
revealed that for non-pre-cxposed rats, Paired and
IJnpairecl groups were statistically similar [ t < 1 ]
(Fig. 3C, Trial 1). E-Iowever, chronic caffeine pre-exposure
potentiated acute al~iphetamine-induced activity
[ t ( l l ) = 4.21, P < 0.011 (Fig. 3D, Trial 1).
Activity data illustrated in Figs 3C and D contrast Paired
and Unpaircd groups for non-pre-exposed and caffeine
pre-exposed rats, rcspcctivcly. Omnibus ANOVA for
Trisls 2-10 revealed a significant main effect of Trial
[F(8,280) = 2.75, P < 0.011, of Group [F(1,35) = 94.01,
I-'< 0.0011, and of Dose [F(1,35) = 4.78, P < 0.051. T h e
Group x Trial interaction [F(8,280) = 2.90, P < 0.01 f was
also significant, indicating that activity in Paired and
Unpaired groups diverged across trials. T h e Dose x Group
interaction [F(1,35) = 4.69, P < 0.051 was also significant; howcvc~;tlie Dose trial and Group x Dose x Trials
interactions were not significant [Fs 5 1.223. T h e main
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Fig. 3
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Locomotor activity for rats treated with 0.5 mglkg amphetamine (Experiment 2). (A) and (B) contrast 0 versus 30 mglkg caffeine pre-exposure
for Unpaired and Paired groups, respectively. (C) and (Dl contrast Paired versus Unpaired groups for rats pre-exposed to 0 and 30rnglkg caffeine.
(E) Activity data from the drug-free test for conditioning. * 30 mglkg pre-exposed Paired rats were more active than comparable Unpaired controls
on Trial 1.

effect of Dose and the Group x Dose intcraction
indicates that pre-exposure to caffeine potentiated
amphetarnine-induced activity (i.c. only the pre-exposed
Paired group). This enhancerneut in activity, relative to
tlze comparable non-preexposed group, was consistent
across trials.
Drug-free test

Rgure 3E illustrates data from the drug-free test for
conditioning. Analyses of these data revealed a main
effect of Group [b'(1,35)= 77.97, P < 0.0011, indicating
conditioned hyperactivity in Paired rats. T h e main effect
of Dose [F(1,35)= 2.621 and t h e Group x Dose interaction [ F < 11 were not significant.

Discussion
Althougl~caffeine can be a potent anorexic (see Gans,
1984), there were no significant differences in weight
between rats pre-exposed to caffeine and those preexposed to saline in the present worlr. Caffeine preexposure did not have any non-specific effects 011 initial
activity in a novel environment or habituation (decrease
in activity) over trials, in Unpaired rats. Thus, differences
in activity after chronic caffeine exposure cannot b e
attributed to non-specific cffects on weight, environmental familiarization, or general motor activity.
Depending on the situation, nicotine produces locomotor
suppression in rats; tl~is suppression is rcplaced with
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enhanced activity aftcr repeated nicotine treatment (e.g.
C:larlie and Kurnar, 198.3; Icita c.t trL, 1992; Ksir, 1994;
Bevins rfrd., 2001). We replicated this pattern of activity
in controls, and found that the general biplirtsic locomoto~
effects of nicotine were still present after prc-exposure to
caffcinc. Chffeinc pre-exposure did not affect r~cutc
activity induced by 0.421 or 0.175 mg/lrg nicotine (i.c.
first conditioning tri:ll for IJrlired rats). This outcome
appears to contrast with prcvious caffeine prc-exposure
research demonstrating cnlianccd hyperactivity aftcr an
acute nicotinc clinllcnge (Chior c.t rd., 2000). I11 tliat
study, rats were injected s.c. with nicotine (0.3 or
0.56 ~iiE/lcgsalt; 0.105 or 0.196 mdlrg expressed as base,
respectively), aftcr which activity was monitored for
60 min. I-Iowevel; due to tlic procedufill restrictions of
equating nctivity tests with nicotine discrirnini~tiontests,
activity for the first 15 min was not included in the
analyses of that study. In contrast, we cxa~iiinctl the
effects of nicotine imriicdiatcly after ridministriition and
for only 30 min. More importantly, Gasior et crl. (2000) did
not suspend cril'feine exposure bcfore the nicotinc
challenge test; rats hacl lice access to cafkinc in the
lionie cage until just before the nicotinc challenge. 'I'his
manipulation opens the possibility chat tlie acute
psyclio~iiotorcffcct was due to tlie presence of both
drugs at the time of testing, t7~1rtliereviclencc for this
possibility has recently bcen publislicd. In a sirnilrlr
nicotine-discrimination study, Gasior rf nl. (2002) demonstrated tliat, regardless of tlie chronic exposure condition
(i.e, caffei~ic-wateror tap-water), pretreatment with an
i.p. injection of caffcinc (10, 17 or 30 mdljkg) enlinnccd
genclxlizztion to a 'threshold' dose of nicotinc (i.e.
0.05 mdkg bizsc). 'l'his fillding clearly i~ldicatcsthilt the
co-presence of nicotinc and caffci~iecan have important
.
in testing protobehavioral effects. W i e t h e ~differcnccs
col, or other procedural vnria~ions,such as nicotine dose,
route of caffeine administratiori, or the co-presence of
caffeine and nicotinc in the rat at t h e t i ~ n cof testing,
account for between-study differences will require
further experimentation.

implicated in the psychornotor effects of ;unplietatnine
(c.g. Okada of {TI!, 1996, 1997; Afi~nas'evcJt rd, 2000;
%aliniser c.t crL, 2000). O n e possibility is chat pre-exposurc
LO caffeine alters tlic niesolimbic dopaminc (DA) system,
such tliat it is Inore sensitive to amphetil~nine, For
example, c o n t ~ l a t c r u l rotational beh;lvior elicited by
6-liydroxydopan~illelesions
caffeinc in KITS wit11 utiili~t~rttl
of thc nigro-striatol patliwly is rzttenuilted 17y tlic IIA D;!
receptor antngonist, cticlopridc (Garrett and I-Ioltzman,
1995). Also, tlic locomotor hyperactivity produced by
cafi'cinc in rats is attenuated by systemic administration
of the IIA 11, receptor subtype antagonist SCI-I 23390
and lie ]>A I>., receptor subtype an~agonistscticlopridc
and sulpiridc (Garrett arid Holtzrnan, 1994). T h e s e
altc~ltions~ u i g h tdepend on tlie antagonistic interaction
bctcvccn adenosine and dopaniinc receptors (e.g. k r r k cy
rIl., 1992, see lircdliolm rf rd, 1999 for a review). T h a t is,
arlcnosine~gic antagotiism by caffeine might disrupt
inhibitory el'fects of etidogenous adenosine on LIA 131
and
receptor affinity. I-Iowcvcr, tlic potential role for
other neurotransmitter systems altered by chronic prcexposure to caffeine should not be overlooked (e.g. Slii r.t
t d , 1994; Jacobson c~ (id,1996; 1;rcdliolm c.t rd, 1999; scc
Ilaly, 1993 for a revie\v).

Caffeine enhances tlie psycliomotor stimulant cffects of
amphetamine in an ilcute challenge (Gasior rr nL, 2000).
tliis finding and extended it to include a
We co~~finned
chronic situation (i.e. repeated daily administration for 10
days). This outcome extends tlie literature demonstrating that chronic exposure to one drug of abuse can
enhance tlie effects of another drug (e.g. Vezitin ef d ,
1989; Vezina and Stewart, 1990; Kuribara, 1999; Xu and
Domino, 1999).

We chanlr Dawn Metschke for assistance in conducting
chis research and Joyce Besheer and Kartpagani 1Z:trthigeyan for their helpful comments on a previous version of
this manuscript.

Amplietamine-conditioned hyperactivity in a drug-frce
test wris unaffected by caffeine prc-exposure, despite rlie
cnliancenicnt of amplicta~~iine-induccd
activity Similarly,
nicotine-conditioncd hyperactivity was unaffcctcd by
cnffeinc prc-cxposurc. Clearly, much rnore parametric
work is required before concluding t h a ~caffeine preexposure c;unnot retard or cnhance an association
between enviro~irnentalcues and the psycliomotor effects
of i~mphctamine or nico~inc. Such variables include
umphct:zrnit~c and nicotine doscs, conrlitioning trial
parameters (e.g. number of trials, trial duration, i~ijcction
to placement interval), and pre-exposure parameters
(ilcJniinistration route, inter-dose interval, dose, duration,
etc.).
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Potentiation of aniplietamine-induced locolnotor activity
by caffeine might reflect changes In the underlying neural
processes cornnlon to both drugs. T h e r e is co~lverging
evidence that the psycliomotor effects of caffeine are
mediated by the same ~nesolimbicdopamine structures
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